Currents of Hope:: How Deep Transcranial Magnetic Stimulation is Reshaping Mental Health and Addiction Treatment
Information
Date & Time
-
-
Location
-
1100 Stanford Dr
1100 Stanford Drive
Coral Gables, FL 33146
Brought to you by
Learning Objectives
Participants will be able to:
-
List 2 or more FDA-cleared indications and protocols for TMS.
-
Describe 3 or more characteristics of patients most likely to benefit from TMS.
-
Describe current patterns of TMS dosing.
Educational Goal
The educational goal of this workshop is to provide the audience with a foundation of knowledge regarding the currently FDA-cleared indications for TMS as well as emerging trends in utilization.
Description
This session will provide the audience with a basic introduction to transcranial magnetic stimulation as a non-invasive FDA-cleared treatment for a variety of psychiatric disorders including depression, obsessive compulsive disorder, and addiction. Additionally, the workshop will introduce new innovations, and new areas of emerging research in the TMS therapeutics field.
Target Audience
- Counselor
- Marriage & Family Therapist
- Medical Doctor
- Psychologist
- Social Worker
- Substance Use Disorder Professionals
Presenters
Dr. Hanlon is a globally recognized pioneer in the non-invasive neuromodulation field. She is particularly well known for her contributions to developing TMS as a non-invasive therapeutic tool for addiction. Prior to joining BrainsWay in 2022 as the Vice President of Medical Affairs and Director of the Innovation Team at BrainsWay, Dr. Hanlon was a tenured professor at the Wake Forest School of Medicine wherein she ran the Clinical Neuromodulation Laboratory. During her 17 years of academic research, she received over $12 million in National Institute of Health funding and led over 15 clinical studies of TMS. She has published over 100 peer-reviewed publications, and mentored over 70 trainees in brain imaging and TMS.
In 2023 she received the International Brain Stimulation Early Career Investigator award. She is the senior author on the inaugural ‘Consensus Paper’ on Non-Invasive Therapeutic Development for Addiction.
Raised in Florida, Dr. Hanlon attended the University of Florida. She received a Ph.D. in neurobiology from Duke University in 2005. She is actively engaged in education and training in brain stimulation, nationally and internationally, and derives intense satisfaction from teaching others about the science, research, and practicalities of delivering new TMS therapeutics to patients.